Related Experiment Video

Updated: May 12, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Management of venous thromboembolism--controversies and the future

David Keeling1, Raza Alikhan

  • 1Oxford University Hospitals, Oxford, UK. david.keeling@ndm.ox.ac.uk

British Journal of Haematology
|March 28, 2013
PubMed

Insights

Managing venous thromboembolism (VTE) presents challenges, including calf vein thrombosis diagnosis and long-term anticoagulation decisions for unprovoked events. This review explores current dilemmas and the introduction of new anticoagulants.

Area of Science:

  • Hematology
  • Vascular Medicine
  • Clinical Practice Guidelines

Background:

  • Existing evidence-based guidelines for venous thromboembolism (VTE) management contain controversial areas.
  • Discrepancies exist globally regarding the significance and management of calf vein thrombosis.
  • Uncertainty surrounds optimal long-term anticoagulation strategies for unprovoked VTE events.

Purpose of the Study:

  • To explore current difficult and controversial areas in venous thromboembolism management.
  • To discuss the challenges in reducing post-thrombotic syndrome incidence.
  • To address the complexities of cancer screening in VTE patients and the integration of novel anticoagulants.

Main Methods:

  • Review of existing literature and clinical guidelines on venous thromboembolism.
  • Analysis of current controversies in VTE diagnosis and treatment.
  • Discussion of emerging challenges with new anticoagulant therapies and their clinical implementation.

Main Results:

  • Significant debate exists on the management of calf vein thrombosis.
  • Decisions regarding long-term anticoagulation for unprovoked VTE are complex.
  • The optimal approach to cancer screening in VTE patients remains contentious.

Conclusions:

  • Venous thromboembolism management requires addressing several unresolved clinical dilemmas.
  • The introduction of new anticoagulants necessitates careful logistical planning and cost-effectiveness evaluation.
  • Further research and consensus are needed to refine VTE management strategies.

More Related Videos

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...